Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Sell
41
BANX Quote, Financials, Valuation and Earnings
Last price:
$21.45
Seasonality move
:
-1.43%
Day range:
$21.46 - $21.66
52-week range:
$17.99 - $23.67
Dividend yield:
8.39%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
15.4K
Avg. volume:
14.1K
1-year change:
2.48%
Market cap:
--
Revenue:
$23.2M
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
BANX
ArrowMark Financial
|
-- | -- | -- | -- | -- |
|
BTO
John Hancock Financial Opportunities Fund
|
-- | -- | -- | -- | -- |
|
FXO
First Trust Financials AlphaDEX Fund
|
-- | -- | -- | -- | -- |
|
GRX
Gabelli Healthcare & WellnessRx Trust
|
-- | -- | -- | -- | -- |
|
IAK
iShares US Insurance ETF
|
-- | -- | -- | -- | -- |
|
IAT
iShares US Regional Banks ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
BANX
ArrowMark Financial
|
$21.46 | -- | -- | -- | $0.40 | 8.39% | -- |
|
BTO
John Hancock Financial Opportunities Fund
|
$35.29 | -- | -- | -- | $0.65 | 7.37% | -- |
|
FXO
First Trust Financials AlphaDEX Fund
|
$59.82 | -- | -- | -- | $0.24 | 1.79% | -- |
|
GRX
Gabelli Healthcare & WellnessRx Trust
|
$9.57 | -- | -- | -- | $0.17 | 6.69% | -- |
|
IAK
iShares US Insurance ETF
|
$131.85 | -- | -- | -- | $0.51 | 1.8% | -- |
|
IAT
iShares US Regional Banks ETF
|
$53.70 | -- | -- | -- | $0.40 | 2.69% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
BANX
ArrowMark Financial
|
-- | 0.022 | -- | -- |
|
BTO
John Hancock Financial Opportunities Fund
|
-- | 1.216 | -- | -- |
|
FXO
First Trust Financials AlphaDEX Fund
|
-- | 1.195 | -- | -- |
|
GRX
Gabelli Healthcare & WellnessRx Trust
|
-- | 0.236 | -- | -- |
|
IAK
iShares US Insurance ETF
|
-- | 0.235 | -- | -- |
|
IAT
iShares US Regional Banks ETF
|
-- | 1.676 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
BANX
ArrowMark Financial
|
-- | -- | -- | -- | -- | -- |
|
BTO
John Hancock Financial Opportunities Fund
|
-- | -- | -- | -- | -- | -- |
|
FXO
First Trust Financials AlphaDEX Fund
|
-- | -- | -- | -- | -- | -- |
|
GRX
Gabelli Healthcare & WellnessRx Trust
|
-- | -- | -- | -- | -- | -- |
|
IAK
iShares US Insurance ETF
|
-- | -- | -- | -- | -- | -- |
|
IAT
iShares US Regional Banks ETF
|
-- | -- | -- | -- | -- | -- |
ArrowMark Financial vs. Competitors
-
Which has Higher Returns BANX or BTO?
John Hancock Financial Opportunities Fund has a net margin of -- compared to ArrowMark Financial's net margin of --. ArrowMark Financial's return on equity of -- beat John Hancock Financial Opportunities Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BANXArrowMark Financial-- -- -- BTOJohn Hancock Financial Opportunities Fund-- -- -- -
What do Analysts Say About BANX or BTO?
ArrowMark Financial has a consensus price target of --, signalling downside risk potential of --. On the other hand John Hancock Financial Opportunities Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that ArrowMark Financial has higher upside potential than John Hancock Financial Opportunities Fund, analysts believe ArrowMark Financial is more attractive than John Hancock Financial Opportunities Fund.
Company Buy Ratings Hold Ratings Sell Ratings BANXArrowMark Financial0 0 0 BTOJohn Hancock Financial Opportunities Fund0 0 0 -
Is BANX or BTO More Risky?
ArrowMark Financial has a beta of 0.243, which suggesting that the stock is 75.692% less volatile than S&P 500. In comparison John Hancock Financial Opportunities Fund has a beta of 1.177, suggesting its more volatile than the S&P 500 by 17.712%.
-
Which is a Better Dividend Stock BANX or BTO?
ArrowMark Financial has a quarterly dividend of $0.40 per share corresponding to a yield of 8.39%. John Hancock Financial Opportunities Fund offers a yield of 7.37% to investors and pays a quarterly dividend of $0.65 per share. ArrowMark Financial pays -- of its earnings as a dividend. John Hancock Financial Opportunities Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BANX or BTO?
ArrowMark Financial quarterly revenues are --, which are smaller than John Hancock Financial Opportunities Fund quarterly revenues of --. ArrowMark Financial's net income of -- is lower than John Hancock Financial Opportunities Fund's net income of --. Notably, ArrowMark Financial's price-to-earnings ratio is -- while John Hancock Financial Opportunities Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ArrowMark Financial is -- versus -- for John Hancock Financial Opportunities Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BANXArrowMark Financial-- -- -- -- BTOJohn Hancock Financial Opportunities Fund-- -- -- --
-
Which has Higher Returns BANX or FXO?
First Trust Financials AlphaDEX Fund has a net margin of -- compared to ArrowMark Financial's net margin of --. ArrowMark Financial's return on equity of -- beat First Trust Financials AlphaDEX Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BANXArrowMark Financial-- -- -- FXOFirst Trust Financials AlphaDEX Fund-- -- -- -
What do Analysts Say About BANX or FXO?
ArrowMark Financial has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust Financials AlphaDEX Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that ArrowMark Financial has higher upside potential than First Trust Financials AlphaDEX Fund, analysts believe ArrowMark Financial is more attractive than First Trust Financials AlphaDEX Fund.
Company Buy Ratings Hold Ratings Sell Ratings BANXArrowMark Financial0 0 0 FXOFirst Trust Financials AlphaDEX Fund0 0 0 -
Is BANX or FXO More Risky?
ArrowMark Financial has a beta of 0.243, which suggesting that the stock is 75.692% less volatile than S&P 500. In comparison First Trust Financials AlphaDEX Fund has a beta of 1.117, suggesting its more volatile than the S&P 500 by 11.701%.
-
Which is a Better Dividend Stock BANX or FXO?
ArrowMark Financial has a quarterly dividend of $0.40 per share corresponding to a yield of 8.39%. First Trust Financials AlphaDEX Fund offers a yield of 1.79% to investors and pays a quarterly dividend of $0.24 per share. ArrowMark Financial pays -- of its earnings as a dividend. First Trust Financials AlphaDEX Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BANX or FXO?
ArrowMark Financial quarterly revenues are --, which are smaller than First Trust Financials AlphaDEX Fund quarterly revenues of --. ArrowMark Financial's net income of -- is lower than First Trust Financials AlphaDEX Fund's net income of --. Notably, ArrowMark Financial's price-to-earnings ratio is -- while First Trust Financials AlphaDEX Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ArrowMark Financial is -- versus -- for First Trust Financials AlphaDEX Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BANXArrowMark Financial-- -- -- -- FXOFirst Trust Financials AlphaDEX Fund-- -- -- --
-
Which has Higher Returns BANX or GRX?
Gabelli Healthcare & WellnessRx Trust has a net margin of -- compared to ArrowMark Financial's net margin of --. ArrowMark Financial's return on equity of -- beat Gabelli Healthcare & WellnessRx Trust's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BANXArrowMark Financial-- -- -- GRXGabelli Healthcare & WellnessRx Trust-- -- -- -
What do Analysts Say About BANX or GRX?
ArrowMark Financial has a consensus price target of --, signalling downside risk potential of --. On the other hand Gabelli Healthcare & WellnessRx Trust has an analysts' consensus of -- which suggests that it could fall by --. Given that ArrowMark Financial has higher upside potential than Gabelli Healthcare & WellnessRx Trust, analysts believe ArrowMark Financial is more attractive than Gabelli Healthcare & WellnessRx Trust.
Company Buy Ratings Hold Ratings Sell Ratings BANXArrowMark Financial0 0 0 GRXGabelli Healthcare & WellnessRx Trust0 0 0 -
Is BANX or GRX More Risky?
ArrowMark Financial has a beta of 0.243, which suggesting that the stock is 75.692% less volatile than S&P 500. In comparison Gabelli Healthcare & WellnessRx Trust has a beta of 0.988, suggesting its less volatile than the S&P 500 by 1.197%.
-
Which is a Better Dividend Stock BANX or GRX?
ArrowMark Financial has a quarterly dividend of $0.40 per share corresponding to a yield of 8.39%. Gabelli Healthcare & WellnessRx Trust offers a yield of 6.69% to investors and pays a quarterly dividend of $0.17 per share. ArrowMark Financial pays -- of its earnings as a dividend. Gabelli Healthcare & WellnessRx Trust pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BANX or GRX?
ArrowMark Financial quarterly revenues are --, which are smaller than Gabelli Healthcare & WellnessRx Trust quarterly revenues of --. ArrowMark Financial's net income of -- is lower than Gabelli Healthcare & WellnessRx Trust's net income of --. Notably, ArrowMark Financial's price-to-earnings ratio is -- while Gabelli Healthcare & WellnessRx Trust's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ArrowMark Financial is -- versus -- for Gabelli Healthcare & WellnessRx Trust. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BANXArrowMark Financial-- -- -- -- GRXGabelli Healthcare & WellnessRx Trust-- -- -- --
-
Which has Higher Returns BANX or IAK?
iShares US Insurance ETF has a net margin of -- compared to ArrowMark Financial's net margin of --. ArrowMark Financial's return on equity of -- beat iShares US Insurance ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BANXArrowMark Financial-- -- -- IAKiShares US Insurance ETF-- -- -- -
What do Analysts Say About BANX or IAK?
ArrowMark Financial has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Insurance ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that ArrowMark Financial has higher upside potential than iShares US Insurance ETF, analysts believe ArrowMark Financial is more attractive than iShares US Insurance ETF.
Company Buy Ratings Hold Ratings Sell Ratings BANXArrowMark Financial0 0 0 IAKiShares US Insurance ETF0 0 0 -
Is BANX or IAK More Risky?
ArrowMark Financial has a beta of 0.243, which suggesting that the stock is 75.692% less volatile than S&P 500. In comparison iShares US Insurance ETF has a beta of 0.664, suggesting its less volatile than the S&P 500 by 33.647%.
-
Which is a Better Dividend Stock BANX or IAK?
ArrowMark Financial has a quarterly dividend of $0.40 per share corresponding to a yield of 8.39%. iShares US Insurance ETF offers a yield of 1.8% to investors and pays a quarterly dividend of $0.51 per share. ArrowMark Financial pays -- of its earnings as a dividend. iShares US Insurance ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BANX or IAK?
ArrowMark Financial quarterly revenues are --, which are smaller than iShares US Insurance ETF quarterly revenues of --. ArrowMark Financial's net income of -- is lower than iShares US Insurance ETF's net income of --. Notably, ArrowMark Financial's price-to-earnings ratio is -- while iShares US Insurance ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ArrowMark Financial is -- versus -- for iShares US Insurance ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BANXArrowMark Financial-- -- -- -- IAKiShares US Insurance ETF-- -- -- --
-
Which has Higher Returns BANX or IAT?
iShares US Regional Banks ETF has a net margin of -- compared to ArrowMark Financial's net margin of --. ArrowMark Financial's return on equity of -- beat iShares US Regional Banks ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BANXArrowMark Financial-- -- -- IATiShares US Regional Banks ETF-- -- -- -
What do Analysts Say About BANX or IAT?
ArrowMark Financial has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Regional Banks ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that ArrowMark Financial has higher upside potential than iShares US Regional Banks ETF, analysts believe ArrowMark Financial is more attractive than iShares US Regional Banks ETF.
Company Buy Ratings Hold Ratings Sell Ratings BANXArrowMark Financial0 0 0 IATiShares US Regional Banks ETF0 0 0 -
Is BANX or IAT More Risky?
ArrowMark Financial has a beta of 0.243, which suggesting that the stock is 75.692% less volatile than S&P 500. In comparison iShares US Regional Banks ETF has a beta of 1.070, suggesting its more volatile than the S&P 500 by 6.983%.
-
Which is a Better Dividend Stock BANX or IAT?
ArrowMark Financial has a quarterly dividend of $0.40 per share corresponding to a yield of 8.39%. iShares US Regional Banks ETF offers a yield of 2.69% to investors and pays a quarterly dividend of $0.40 per share. ArrowMark Financial pays -- of its earnings as a dividend. iShares US Regional Banks ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BANX or IAT?
ArrowMark Financial quarterly revenues are --, which are smaller than iShares US Regional Banks ETF quarterly revenues of --. ArrowMark Financial's net income of -- is lower than iShares US Regional Banks ETF's net income of --. Notably, ArrowMark Financial's price-to-earnings ratio is -- while iShares US Regional Banks ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ArrowMark Financial is -- versus -- for iShares US Regional Banks ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BANXArrowMark Financial-- -- -- -- IATiShares US Regional Banks ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Sell
50
TGL alert for Dec 8
Treasure Global, Inc. [TGL] is up 3.18% over the past day.
Buy
56
SMX alert for Dec 8
SMX (Security Matters) Plc [SMX] is down 47.34% over the past day.
Buy
62
PRAX alert for Dec 8
Praxis Precision Medicines, Inc. [PRAX] is up 10.21% over the past day.
